Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Current Gene Therapy|July 4, 2019
The Synergy between CRISPR and Chemical EngineeringCia-Hin Lau, Chung TinFaculty Reviews|March 4, 2021
CRISPR-based strategies for targeted transgene knock-in and gene correctionCia-Hin Lau, Chung Tin, Yousin SuhCellular and Molecular Life Sciences : CMLS|September 17, 2024
Extended replicative lifespan of primary resting T cells by CRISPR/dCas9-based epigenetic modifiers and transcriptional activatorsSiping Huang, Cia-Hin Lau, Chung Tin, et al.Molecular Therapy. Methods & Clinical Development|June 27, 2022
PAM-flexible dual base editor-mediated random mutagenesis and self-activation strategies to improve CRISPRa potencyCia-Hin Lau, Siping Huang, Raymond H W Lam, et al.Molecular Therapy. Nucleic Acids|May 21, 2019
Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRaCia-Hin Lau, Jonathan Weng-Thim Ho, Pik Kwan Lo, et al.The CRISPR Journal|April 26, 2019
Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational ResearchCia-Hin LauBiosensors & Bioelectronics|November 11, 2022
Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotidesChenyu Cui, Cia-Hin Lau, Lok Ting Chu, et al.Cardiovascular Diabetology|January 22, 2011
Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control studyCia-Hin Lau, Sekaran MuniandyAnnals of Human Genetics|February 18, 2011
Adiponectin and resistin gene polymorphisms in association with their respective adipokine levelsCia-Hin Lau, Sekaran MuniandyF1000Research|January 16, 2018
<i>In vivo</i> genome editing in animals using AAV-CRISPR system: applications to translational research of human diseaseCia-Hin Lau, Yousin SuhPageof 9